13D/13G Filings - KalVista Pharmaceuticals Inc. (KALV)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
11:53 am
Sale
2021-12-31 13G KalVista Pharmaceuticals, Inc.
KALV
Eventide Asset Management, LLC 138,821
0.600%
-1,541,179decrease
(-91.74%)
Filing
History
2022-02-14
08:57 am
Purchase
2021-12-31 13G KalVista Pharmaceuticals, Inc.
KALV
Deep Track Capital, LP 1,500,000
6.130%
233,116increase
(+18.40%)
Filing
History
2022-02-11
5:28 pm
Unchanged
2021-12-31 13G KalVista Pharmaceuticals, Inc.
KALV
Vivo Ventures VI LLC 1,383,179
5.700%
0
(Unchanged)
Filing
History
2022-02-11
5:03 pm
Purchase
2021-12-31 13G KalVista Pharmaceuticals, Inc.
KALV
SUVRETTA CAPITAL MANAGEMENT, LLC 1,746,300
7.100%
449,848increase
(+34.70%)
Filing
History
2022-02-11
4:09 pm
Sale
2021-12-31 13G KalVista Pharmaceuticals, Inc.
KALV
Flynn James E 1,175,131
4.800%
-630,906decrease
(-34.93%)
Filing
History
2022-02-10
5:11 pm
Sale
2021-02-09 13D KalVista Pharmaceuticals, Inc.
KALV
Longwood Fund II L.P. 7,801
0.030%
-926,683decrease
(-99.17%)
Filing
History
2022-02-04
2:31 pm
Purchase
2021-12-31 13G KalVista Pharmaceuticals, Inc.
KALV
FRANKLIN RESOURCES INC
BEN
1,252,142
5.100%
1,252,142increase
(New Position)
Filing
History
2022-02-04
09:27 am
Purchase
2021-12-31 13G KalVista Pharmaceuticals, Inc.
KALV
Wellington Management Group LLP 1,811,505
7.400%
1,811,505increase
(New Position)
Filing
History
2022-01-31
5:49 pm
Purchase
2021-12-31 13G KalVista Pharmaceuticals, Inc.
KALV
BlackRock Inc.
BLK
1,504,620
6.100%
391,240increase
(+35.14%)
Filing
History
2022-01-31
5:00 pm
Purchase
2022-01-26 13D KalVista Pharmaceuticals, Inc.
KALV
Frazier Life Sciences Public Fund, L.P. 1,572,192
6.400%
303,463increase
(+23.92%)
Filing
History
2021-12-30
4:33 pm
Purchase
2021-12-21 13D KalVista Pharmaceuticals, Inc.
KALV
Frazier Life Sciences Public Fund, L.P. 1,268,729
5.200%
1,268,729increase
(New Position)
Filing
History
2021-10-25
5:16 pm
Purchase
2021-10-21 13G KalVista Pharmaceuticals, Inc.
KALV
Deep Track Capital, LP 1,266,884
5.180%
1,266,884increase
(New Position)
Filing
History
2021-09-17
4:54 pm
Purchase
2021-09-07 13G KalVista Pharmaceuticals, Inc.
KALV
SUVRETTA CAPITAL MANAGEMENT, LLC 1,296,452
5.300%
1,296,452increase
(New Position)
Filing
History
2021-06-10
11:37 am
Sale
2021-06-09 13G KalVista Pharmaceuticals, Inc.
KALV
FMR LLC 1,011,500
4.141%
-628,778decrease
(-38.33%)
Filing
History
2021-05-27
4:44 pm
Purchase
2021-05-24 13G KalVista Pharmaceuticals, Inc.
KALV
RA Capital Management, L.P. 1,399,489
5.700%
613,219increase
(+77.99%)
Filing
History
2021-05-07
4:56 pm
Purchase
2021-04-27 13G KalVista Pharmaceuticals, Inc.
KALV
Flynn James E 1,806,037
7.430%
1,806,037increase
(New Position)
Filing
History
2021-02-16
4:03 pm
Sale
2021-02-09 13D KalVista Pharmaceuticals, Inc.
KALV
SVLSF IV LLC 0
0.000%
-1,769,576decrease
(Position Closed)
Filing
History
2021-02-16
08:31 am
Purchase
2020-12-31 13G KalVista Pharmaceuticals, Inc.
KALV
Ikarian Capital LLC 1,063,961
5.900%
117,356increase
(+12.40%)
Filing
History
2021-02-12
4:30 pm
Purchase
2020-12-31 13G KalVista Pharmaceuticals, Inc.
KALV
Vivo Ventures VI LLC 1,383,179
5.900%
360,686increase
(+35.28%)
Filing
History
2021-02-08
10:25 am
Sale
2021-02-05 13G KalVista Pharmaceuticals, Inc.
KALV
FMR LLC 1,640,278
9.142%
-150,513decrease
(-8.40%)
Filing
History
Goto Prev, 0, 1, 2, 3, Next